Waleed Ghanima

28.06.2021: We now have a good understanding of the acute complications of COVID-19, but we know less about possible long-term sequelae. The aim of this case report is to raise awareness of subacute thyroiditis as a potential complication of COVID-19. A previously healthy man in his forties who used no regular...

14.12.2020: The clinical picture associated with COVID-19 can vary from asymptomatic to acute respiratory distress syndrome (ARDS) and death (1). It is estimated that 15–40 % of patients hospitalised with COVID-19 will require treatment in intensive care (1, 2). The disease appears to affect all age groups...

24.06.2020: Intensification of antithrombotic therapy can reduce morbidity and mortality in patients with established atherosclerosis. The treatment strategy ought to be incorporated into Norwegian guidelines. Atherosclerosis causes a weakening or stenosis of the arterial walls and is a pathophysiological cause...

21.08.2018: Adverse reaction reports to regional medicines information and pharmacovigilance centres show that severe haemorrhages are the most dangerous adverse reactions to direct-acting oral anticoagulants. Since direct-acting oral anticoagulants (DOACs) were introduced in 2012, their use has steadily...

11.10.2016: The use of new, direct anticoagulants is increasing. Data from both controlled trials and clinical practice have shown that these drugs are as efficacious and safe as warfarin for deep vein thrombosis and pulmonary embolism, and as stroke prophylaxis for patients with atrial fibrillation. But what...

01.10.2013: Anticoagulation treatment is necessary for preventing and treating a number of thromboembolic conditions. It is well known that warfarin treatment provides effective protection against thrombosis, but the treatment is made difficult by the small therapeutic window, wide dose-response variation, many...